Geneos Wealth Management’s BNY Mellon US Mid Cap Core Equity ETF BKMC Stock Holding History
Bought
Maintained
Sold
Other funds holding BKMC
RA
FTUS
DWM
ZF
Geneos Wealth Management's BKMC Position: Q1 2026 in Review
Geneos Wealth Management increased its BNY Mellon US Mid Cap Core Equity ETF (BKMC) stake by 1.9% in Q1 2026, buying an estimated $150K and bringing the position to 208,545 shares worth $7.67M. The position accounts for 0.18% of the portfolio, ranked #134.
Geneos Wealth Management first reported a position in BKMC in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.75M in Q1 2025. 38 funds tracked by Wall St. Rank hold BKMC as of Q1 2026.
- Geneos Wealth Management held 208,545 shares of BNY Mellon US Mid Cap Core Equity ETF worth $7.67M as of Q1 2026.
- Geneos Wealth Management bought 3,930 BNY Mellon US Mid Cap Core Equity ETF shares in Q1 2026, an estimated $150K.
- BNY Mellon US Mid Cap Core Equity ETF made up 0.18% of Geneos Wealth Management's portfolio in Q1 2026, its #134 holding.
- Geneos Wealth Management first reported a position in BNY Mellon US Mid Cap Core Equity ETF in Q4 2020 and has held it in 22 quarters since.
- Geneos Wealth Management's BNY Mellon US Mid Cap Core Equity ETF position peaked at $8.75M in Q1 2025.
- 38 funds tracked by Wall St. Rank held BNY Mellon US Mid Cap Core Equity ETF as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.